Impact Partnership Wealth LLC Purchases 70 Shares of DaVita Inc. (NYSE:DVA)

Impact Partnership Wealth LLC boosted its position in DaVita Inc. (NYSE:DVA) by 3.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,941 shares of the company’s stock after acquiring an additional 70 shares during the period. Impact Partnership Wealth LLC’s holdings in DaVita were worth $290,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Secure Asset Management LLC purchased a new stake in shares of DaVita during the 4th quarter valued at approximately $208,000. Janney Montgomery Scott LLC raised its holdings in DaVita by 1.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 25,020 shares of the company’s stock valued at $3,742,000 after acquiring an additional 429 shares during the period. Nisa Investment Advisors LLC lifted its position in shares of DaVita by 10.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 40,500 shares of the company’s stock worth $6,057,000 after acquiring an additional 3,680 shares in the last quarter. Crossmark Global Holdings Inc. boosted its holdings in shares of DaVita by 19.1% in the fourth quarter. Crossmark Global Holdings Inc. now owns 30,769 shares of the company’s stock worth $4,601,000 after acquiring an additional 4,942 shares during the period. Finally, Hennessy Advisors Inc. grew its position in shares of DaVita by 6.9% in the fourth quarter. Hennessy Advisors Inc. now owns 73,300 shares of the company’s stock valued at $10,962,000 after purchasing an additional 4,700 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Up 0.1 %

Shares of NYSE DVA opened at $170.06 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The business has a 50-day moving average of $158.32 and a 200-day moving average of $153.80. The firm has a market capitalization of $13.94 billion, a price-to-earnings ratio of 18.35, a PEG ratio of 0.82 and a beta of 0.92. DaVita Inc. has a 12 month low of $104.70 and a 12 month high of $170.80.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the company earned $2.85 EPS. DaVita’s quarterly revenue was up 4.6% on a year-over-year basis. Sell-side analysts expect that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DVA. Truist Financial increased their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. Barclays increased their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.